ENDOMETRIAL CARCINOMA

Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL CARCINOMA trials appear

Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 3 Not yet finished but already full! 13 Completed 2 Terminated 1

Cancer center tests new drug duo for Tough-to-Treat uterine cancer

Disease control Terminated

This study tested a combination of two drugs, futibatinib and pembrolizumab, for people with a specific type of advanced endometrial (uterine) cancer that had spread and was not responding well to standard chemotherapy. The goal was to see if this new combination could shrink tum…

Matched conditions: ENDOMETRIAL CARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ENDOMETRIAL CARCINOMA

Get alerted when new ENDOMETRIAL CARCINOMA trials appear

Cancer center tests new drug duo for Tough-to-Treat uterine cancer